Market Tracker

03/28 5:16pm ET

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.37
Delayed Data
As of 3:59pm ET
 -0.04 / -2.84%
Today’s Change
0.82
Today|||52-Week Range
1.76
+19.13%
Year-to-Date
No recent news for CASI Pharmaceuticals Inc.

Today’s Trading

Previous close1.41
Today’s open1.36
Day’s range1.36 - 1.41
Volume7,069
Average volume (3 months)49,316
Market cap$84.9M
Dividend yield--
Data as of 3:59pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)+76.09%
Earnings growth (this year)-2.27%
Earnings growth (next 5 years)--
Revenue growth (last year)+101.09%
P/E ratioNM
Price/Sales652.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc-0.06-2.11%
LIFEaTyr Pharma Inc0.000.00%
ATNMActinium Pharmaceuti...+0.08+5.33%
AGRXAgile Therapeutics I...+0.16+5.33%
Data as of 4:01pm ET, 03/28/2017

Financials

Last reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$47.7K
Annual profit (last year)-$7.2M
Net profit margin-15,104.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ken Keyong Ren
COO, Secretary, Vice President &
General Counsel
Cynthia Wong Hu
Corporate headquarters
Rockville, Maryland

Forecasts